Summary
Transforming growth factor β (TGF-β) exerts a growth inhibitory effect on many cell types through binding to two types of receptors, the type I and II receptors. Resistance to TGF-β due to lack of type II receptor (RII) has been described in some cancer types including small cell lung cancer (SCLC). The purpose of this study was to examine the cause of absent RII expression in SCLC cell lines. Northern blot analysis showed that RII RNA expression was very weak in 16 of 21 cell lines. To investigate if the absence of RII transcript was due to mutations, we screened the poly-A tract for mutations, but no mutations were detected. Additional screening for mutations of the RII gene revealed a GG to TT base substitution in one cell line, which did not express RII. This mutation generates a stop codon resulting in predicted synthesis of a truncated RII of 219 amino acids. The nature of the mutation, which has not previously been observed in RII, has been linked to exposure to benzo[a]-pyrene, a component of cigarette smoke. Since RII has been mapped to chromosome 3p22 and nearby loci are often hypermethylated in SCLC, it was examined whether the lack of RII expression was due to hypermethylation. Southern blot analysis of the RII promoter did not show altered methylation patterns. The restriction endonuclease pattern of the RII gene was altered in two SCLC cell lines when digested with Sma1. However, treatment with 5-aza-2′-deoxycytidine did not induce expression of RII mRNA. Our results indicate that in SCLC lack of RII mRNA is not commonly due to mutations and inactivation of RII transcription was not due to hypermethylation of the RII promoter or gene. Thus, these data show that in most cases of the SCLC cell lines, the RII gene and promoter is intact in spite of absent RII expression. However, the nature of the mutation found could suggest that it was caused by cigarette smoking.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Berendsen, H. H., De Leij, L., De Vries, E. G. E., Mesander, G., Mulder, N. H., De Jong, B., Buys, CHCM, Postmus, P. E., Poppema, S., Sluiter, H. J. & The, H. T. (1988). Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res 48: 6891–6899.
Carney, D. N., Gazdar, A. F., Bepler, G., Guccion, J. G., MarangoS, P. J., Moody, T. W., Zweig, M. H. & Minna, J. D. (1985). Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45: 2913–2923.
Cui, W., Kemp, C. J., Duffie, E., Balmain, A. & Akhurst, R. J. (1994). Lack of transforming growth factor-β1 expression in benign skin tumors of p53null mice is prognostic for a high risk of malignant conversion. Cancer Res 54: 5831–5836.
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A. & Akhurst, R. J. (1996). TGF-β1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531–542.
Damstrup, L., Rygaard, K., Spang-Thomsen, M. & Poulsen, H. S. (1993). Expression of the transforming growth factor β (TGFβ) receptors and TGF-β1, TGF-β2 and TGF-β3 in human small cell lung cancer cell lines. Br J Cancer 67: 1015–1021.
de Jonge, R. R., Garrigue-Antar, L., Velluci, V. F. & Reiss, M. (1997). Frequent inactivation of the transforming growth factor β type II receptor in small-cell lung carcinoma cells. Oncology Res 9: 89–98.
De Leil, L., Postmus, P. E., Buys, CHCM, Elema, J. D., Ramaekers, F., Poppema, S., Brouwer, M., Van Der Veen, A. Y., Mesander, G. & The, T. H. (1985). Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res 45: 6024–6033.
Denissenko, M. F., Pao, A., Tang, M-S & Pfeifer, G. P. (1996). Preferential formation of benzoe[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274: 430–432.
Engelholm, S. A., Spang-Thomsen, M., Vindeløv, L. L., Brünner, N., Nielsen, M. H., Hirsch, F. & Hansen, H. H. (1986). Comparison of characteristics of human small cell carcinoma of the lung in patients, in vitro and transplanted into nude mice. Acta Pathol Microbiol Scand Sect A Pathol 94: 325–336.
Ferguson, A. T., Lapidus, R. G., Baylin, S. B. & Davidson, N. E. (1995). Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can activate estrogen receptor expression. Cancer Res 55: 2279–2283.
Garrague-Antar, L., Muñoz-Antonia, T., Antonia, S. J., Gesmonde, J., Velluci, V. F. & Reiss, M. (1995). Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55: 3982–3987.
Geiser, A. G., Burmester, J. K., Webbink, R., Roberts, A. B. & Sporn, M. B. (1992). Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. J Biol Chem 267: 2588–2593.
Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., van Tornout, J. M. & Jones, P. J. (1995). Methylation of 5′CpG island of p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531–4535.
Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarnard, P. F., Isaacs, W. B., Pith, P. M., Davidson, P. M., Davidson, N. E. & Baylin, S. B. (1995). E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195–5199.
Inagaki, M., Moustakas, A., Lin, H. Y., Lodish, H. F. & Carr, B. I. (1993). Growth inhibition by transforming growth factor β (TGF-β) type 1 is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc Natl Acad Sci USA 90: 5359–5363.
Kingsley, D. M. (1994). The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133–146.
Liabakk, N., Talbot, I., Smith, R. A., Wilkinson, K. & Balkwill, F. (1996). Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancers. Cancer Res 56: 190–196.
Lin, H. Y., Wang, X-F, Ng-Eaton, E., Weinberg, R. A. & Lodish, H. F. (1992). Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775–785.
Lu, S-L, Akiyami, Y., Nagasaki, H., Saiton, K. & Yuasa, Y. (1995). Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem Biophys Res Commun 216: 452–457.
Lu, S-L, Zhang, W-C, Akiyami, Y., Nomizu, T. & Yuasa, Y. (1996). Genomic structure of the transforming growth factor β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res 56: 4595–4598.
Makos, M., Nelkin, B. D., Lerman, M. I., Latif, F., Zbar, B. & Baylin, S. B. (1995). Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 89: 1929–1933.
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M. & Willson, J. K. V. (1995). Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268: 1336–1338.
Mathew, S., Murty, VVVS, Cheifetz, S., George, D., Massagué, J. & Chaganti, R. S. K. (1994). Transforming growth factor receptor gene TGFβR2 maps to human chromosome band 3p22. Genomics 20: 114–115.
Mitsudomi, T., Ogana, T., Nishida, A., Usaki, T., Sugio, K., Yasumo, K., Sugimachi, K. & Gazdar, A. F. (1996). Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implications. Clin Cancer Res 2: 1185–1188.
Moses, H. L. (1992). TGFβ regulation of epithelial cell proliferation. Mol Reprod Dev 32: 179–184.
Myeroff, L., Parsons, R., Kim, S-J, Hedrik, L., Rho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., Park, K., Bang, Y-J, Lee, H. Y., Park, J-G, Lynch, H. T., Roberts, A. B., Vogelstein, B. & Markowitz, S. D. (1995). Transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55: 5545–5547.
Nørgaard, P., Damstrup, L., Rygaard, K., Spang-Thomsen, M. & Poulsen, H. S. (1994). Growth suppression by transforming growth factor-β1 of human small cell lung cancer cell lines is associated to expression of the type II receptor. Br J Cancer 69: 802–808.
Nørgaard, P., Hougaard, S., Spang-Thomsen, M. & Poulsen, H. S. (1995). Transforming growth factor β and cancer. Cancer Treat Rev 21: 367–403.
Nørgaard, P., Spang-Thomsen, M. & Poulsen, H. S. (1996). Expression and autoregulation of transforming growth factor β receptor mRNA in small-cell lung cancer cell lines. Br J Cancer 73: 1037–1043.
Park, K., Kim, S-J, Bang, Y-J, Park, J-G, Kim, N. K., Roberts, A. B. & Sporn, M. B. (1994). Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91: 8772–8776.
Pettengill, O. S., Sorenson, G. D., Wurster-Hill, D., Curphey, T. J., Noll, W. W., Cate, C. C. & Maurer, L. H. (1980). Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer (Phila.) 45: 906–918.
Pierce, D. F., Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffey, R. J. Jr & Moses, H. L. (1995). Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc Natl Acad Sci USA 92: 4254–4258.
Roberts, A. B. & Sporn, M. B. (1990). The Transforming Growth Factor-βs. Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors, Sporn MB, Roberts AB (eds), pp. 419–472, Springer Verlag Heidelberg
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory: Cold Spring Harbor, NY
Sun, L., Wu, G., Willson, J. K. V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X-F & Brattain, M. G. (1994). Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449–26455.
Takenoshita, S., Hagiwara, K., Gemma, A., Nagashima, M., Ryberg, D., Lindstedt, B. A., Bennett, W. P., Haugen, A. & Harris, C. C. (1997). Absence of mutations in the transforming growth factor-beta type II receptor in sporadic lung cancers with microsatellite instability and rare H-ras1 alleles. Carcinogenesis 18: 1427–1429.
Tani, M., Takenoshita, S., Kohno, T., Hagiwara, K., Nagamachi, Y., Harris, C. C. & Yokota, J. R. A. (1997). Infrequent mutations of the transforming growth factor beta type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions. Carcinogenesis 18: 1119–1121.
Todd, S., Franklin, W. A., Varella-Garcia, M., Kennedy, T., Hillikwer, C. E., Hahner, L. Jr, Anderson, M., Wiest, J. S., Drabkin, H. A. & Gemmill, R. M. (1997). Homozygous deletions of human chromosome 3p in lung tumors. Cancer Res 57: 1344–1352.
Vincent, F., Nagashima, M., Takenoshita, S., Khan, M. A., Gemma, A., Hagiwara, K. & Bennett, W. P. (1997). Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Oncogene 15: 117–122.
Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. & Brattain, M. G. (1995). Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044–22049.
Wrana, J. L., Attisano, L., Wieser, F., Ventura, F. & Massagué, J. (1994). Mechanism of activation of the TGF-β receptor. Nature 370: 341–347.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Hougaard, S., Nørgaard, P., Abrahamsen, N. et al. Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines. Br J Cancer 79, 1005–1011 (1999). https://doi.org/10.1038/sj.bjc.6690161
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690161
Keywords
This article is cited by
-
Update 2021: Management of Small Cell Lung Cancer
Lung (2021)
-
TGFβ-1 and TGFBR2 polymorphisms, cooking oil fume exposure and risk of lung adenocarcinoma in Chinese nonsmoking females: a case control study
BMC Medical Genetics (2015)
-
EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway
Cell Discovery (2015)
-
Induction of lung epithelial cell transformation and fibroblast activation by Yunnan tin mine dust and their interaction
Medical Oncology (2011)
-
Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes
Cellular Oncology (2011)